Meditrina announces strategic partnership with M.E.D. Surgical to distribute Aveta® System in Ireland and UK
M.E.D Surgical, a division of Uniphar Medtech, today announced a strategic partnership with Meditrina to distribute the innovative Aveta® System throughout Ireland and the United Kingdom. This collaboration combines M.E.D. Surgical's extensive distribution network with Meditrina's groundbreaking women’s health technology.
The Aveta® System is a state-of-the-art medical device designed to provide minimally invasive treatment options for women experiencing abnormal uterine bleeding, fibroids, and other intrauterine pathologies. The Aveta® System was developed for hysteroscopy procedures, allowing healthcare providers to directly visualize and treat intrauterine conditions with precision and minimal patient discomfort.
This FDA-cleared, CE-marked, and UKCA-marked technology offers healthcare providers a safe and effective solution for patients seeking alternatives to traditional surgical interventions. By leveraging advanced hysteroscopic techniques, the Aveta® System, features the smallest insertion diameter with largest working channel operative hysteroscope on the market, enabling detailed examination and targeted treatment of various gynaecological conditions, reducing the need for more invasive surgical procedures.
"We are thrilled to partner with Meditrina to bring the Aveta® System to healthcare providers across Ireland and the UK," said David Laheen, Managing Director of M.E.D. Surgical. "This partnership aligns perfectly with our commitment to delivering innovative medical technologies that improve patient outcomes while reducing healthcare costs."
The Aveta® System's proprietary technology allows gynaecologists to perform procedures safe and effectively in any procedure setting, potentially reducing recovery time, and eliminating the need for general anaesthesia in many cases. Clinical evaluations have demonstrated excellent safety profiles and high user satisfaction rates.
"Meditrina is proud to collaborate with M.E.D. Surgical to expand access to the Aveta® System," said Csaba Truckai, CEO of Meditrina. "Their extensive experience in the medical device sector and strong relationships with healthcare providers make them the ideal partner to help us reach more patients who can benefit from our technology."
The partnership addresses the growing healthcare industry focus on cost-effective treatments that minimize hospital stays while potentially improving patient quality of life.
M.E.D. Surgical will begin distributing the Aveta® System immediately, with comprehensive training and support programs available to healthcare providers interested in adopting this technology.
About M.E.D Surgical
M.E.D Surgical, a division of Uniphar Medtech, is a leading distributor of innovative medical technologies throughout Ireland and the United Kingdom. With decades of experience in the healthcare industry, M.E.D. Surgical partners with leading medtech manufacturers worldwide to bring cutting-edge medical solutions to healthcare providers, focusing on improving patient outcomes and healthcare delivery.
About Meditrina
Meditrina is a medical technology company dedicated to advancing women's health through innovative, minimally invasive solutions. The company's flagship product, the Aveta® System, represents a significant advancement in treating intrauterine pathologies, offering patients and providers an effective alternative to more invasive surgical procedures.
